Refine by
Whole Blood Articles & Analysis
26 news found
We are proud to announce that Advanced Instruments and Nova Biomedical are now officially doing business under a single, unified brand. This is a transformative moment in our journey to deliver greater value to customers across the biopharmaceutical and clinical markets. Starting today we will be also unveiling a refreshed brand identity and logo across the merged organization that reflects our ...
Peripheral blood mononuclear cells (PBMCs), derived from whole blood or leukapheresis, encompass several major immune cell populations including lymphocytes, monocytes, NK cells and dendritic cells. Apheresis material is a PBMC-enriched blood product widely used in cell therapy, the maximum shelf life of which is 48h when ...
Entegrion Announces CE Mark for Point of Care System for Blood Coagulation Monitoring. Regulatory clearance makes Entegrion’s innovative point of care diagnostic instrument for viscoelastic coagulation testing available to clinicians in Europe. ...
The marker-independent ISET technology has already been shown to detect CTC from NSCLC with unparalleled sensitivity and specificity, prior to imaging. However, CTC rarity in usual blood draw volumes can prevent extensive CTC analyses and culture. Diagnostic leukapheresis (DLA) is a robust process that concentrates mononuclear cells, including CTC, from the ...
Ariana Pharma, the leading Al-driven precision medicine company, has announced the first comprehensive blarcamesine pathway analysis impact using extensive data from the ANAVEX®2-73-PDD-001 Parkinson’s Disease Dementia (PDD) clinical study. Initial results were presented by Ariana Pharma at the Alzheimer’s Association International Conference (AAIC 2022) in San Diego, in ...
Key differentiators noted by the authors include faster turn-around time (< 20 minutes), ease of use (tested directly from whole blood, without need for significant laboratory infrastructure) and analytical precision, as noted below. ...
Our recently announced plan to pursue a de Novo regulatory pathway could establish the Symphony IL-6 test as the new standard for measuring IL-6 using whole blood and serve to validate the innovative nature our ...
Proprietary microRNA signature (miRisk) may support immunotherapy treatment decisions as a blood-based complementary diagnostic Results published in Journal of Thoracic Oncology Clinical and Research Reports Hummingbird Diagnostics GmbH, a leader in reading blood-based microRNAs for early disease detection and characterization, today announced a publication ...
“This study illustrates the potential of how miRNAs taken from peripheral whole blood can be analyzed to predict the efficacy of PD-(L)1-targeted therapies in patients with NSCLC and improve patient outcomes. ...
I am thrilled to join Bluejay because it is seeking to offer healthcare providers the opportunity to conduct important tests using whole blood for patients with life threatening conditions in a near-patient setting. ...
--(BUSINESS WIRE)-- Foundation Medicine, Inc. today announced a collaboration with Eli Lilly and Company (Lilly) for the development of Foundation Medicine’s tissue- and blood-based assays as companion diagnostics for RETEVMO® and other therapies in Loxo Oncology at Lilly’s pipeline. ...
* Lectin-based development services According to the official speaker from CD BioGlyco, their service can be utilized for vaccine development, detection kit development, virology research, tools development for microarray, immunoassay, and virus purification from whole blood, and development of biomarkers to predict disease severity. ...
Under the new agreements, TRICARE beneficiaries now have improved access to Foundation Medicine’s FDA-approved comprehensive genomic profiling (CGP) tests, FoundationOne®CDx and FoundationOne®Liquid CDx, in accordance with their approved indications for all solid tumors. Through tissue or blood samples, FoundationOne CDx and FoundationOne Liquid CDx evaluate more ...
Previously exclusive to X-ZELL, the patented system is part of the company’s single-cell diagnostics platform, which is capable of isolating and visualising individual atypical cells from a small 10mL blood sample. According to X-ZELL’s Head of Engineering & Product Development, Sven Strache, the technology is crucial to the routine discovery of next-generation ...
With the addition of MCHC, Prime Plus now offers up to 24 critical care whole blood tests including blood gases, electrolytes, metabolites, and CO-oximetry. This comprehensive test menu helps clinicians rapidly assess acid/base balance, electrolyte balance, glycemic control, kidney function, oxygen carrying capacity of blood, ...
We will present data characterizing the activity of EXS21546 ex vivo in patient-derived whole blood samples. Interrogation of primary cancer cells from pancreatic and lung cancer patients treated with EXS21546 ex vivo by phenotypic image-based screening, demonstrated that EXS21546 reduces the relative fraction of viable cancer cells while inducing an expansion of ...
The test detects specific SARS CoV2 IgG and IgM antibodies in the blood in response to a coronavirus infection. The detection of antibodies can be used to identify those who have already had contact with the virus. ...
The objective was to evaluate the association between CNT/F and ex vivo responses of whole blood challenged with secondary stimulants in a cross-sectional study of 102 workers. ...
Clinical laboratories can now access a complete system developed to enable simultaneous testing of cyclosporine A, everolimus, sirolimus and tacrolimus from a single whole blood sample aspiration using gold standard liquid chromatography-tandem mass spectrometry (LC-MS/MS) technology. The Cascadion analyzer aspirates whole blood ...
At the same time, Grifols - leveraging its capability in developing tailored test for new and emerging pathogens - is accelerating the development of diagnostic and screening high throughput tests in plasma and whole blood screening for the detection of the novel coronavirus through NAT technology. Our hope is to advance the understanding of the virus and the ...